Search for: "BAYER MANUFACTURING"
Results 621 - 640
of 982
Sorted by Relevance
|
Sort by Date
16 Jan 2008, 6:13 am
Under Bayer v. [read post]
25 Apr 2018, 8:08 am
In 2017 Janssen, Bayer and Johnson & Johnson, manufacturers and sellers of Xarelto, won three “bellwether trials” in this MDL, which you can read about here. [read post]
15 Mar 2010, 4:30 am
In that case, the appellate court upheld summary judgment in favor of the drug-manufacturer defendant. [read post]
26 Jan 2011, 2:35 pm
Bayer Corp. (09-1205). [read post]
11 Sep 2018, 2:00 am
Bayer, which bought Monsanto in June, says it will appeal. [read post]
30 Dec 2009, 7:14 am
Yaz and Yasmin are two similar birth control pills that are both manufactured by Bayer, containing a combination of ethinyl estradiol and drospirenone, a new type of progestin. [read post]
29 Sep 2011, 7:52 am
Henry have handled numerous claims against the manufacturers of Yaz because of the severe side effects our clients have endured. [read post]
24 Jul 2019, 9:21 am
Monsanto, a well-known agrochemical giant was the first manufacturer to sell the glyphosate-based herbicide product 'Roundup' back in 1974. [read post]
5 Aug 2009, 6:41 pm
Yaz was introduced in 2006 by Bayer with a slightly lower amount of ethinyl estradoil. [read post]
13 Nov 2011, 7:39 am
More than 9,000 lawsuits have been filed against Bayer Healthcare Pharmaceuticals, Inc., which markets Yaz and Yasmin in the United States, and Bayer Pharma AG, which manufactures drospirenone and ethinyl estradiol, the progestin and estrogen contained in Yaz and Yasmin. [read post]
8 Aug 2010, 10:11 am
The New Jersey Yaz litigation was consolidated because of concerns about court filings, since New Jersey is the corporate headquarters in the United States for Bayer Healthcare Pharmaceuticals, Inc., which manufacturers the birth control pills. [read post]
29 Sep 2011, 7:52 am
Henry have handled numerous claims against the manufacturers of Yaz because of the severe side effects our clients have endured. [read post]
19 Aug 2009, 5:41 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Nexavar (Sorafenib) – India: Patent linkage killed by Delhi High Court and Bayer fined (Spicy IP) US: Jim Greenwood on data exclusivity and healthcare innovation (BiotechBlog) (IP Watchdog) (Patent Docs) General SPCs: good for Europe, bad for India? [read post]
25 Sep 2013, 5:12 pm
Bayer’s U.S. headquarters are based in New Jersey. [read post]
27 Oct 2008, 10:27 am
Oct. 15, 2008), a unanimous panel of the United States Court of Appeals for the Federal Circuit affirmed the summary judgment granted to Bayer by the United States District Court for the Eastern District of New York, holding that Bayer’s settlement of patent litigation with a generic pharmaceutical manufacturer did not violate the antitrust laws. [read post]
18 Oct 2023, 12:39 pm
If so, you may be entitled to compensation from the manufacturer for damages. [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by… [read post]
13 Oct 2010, 8:19 pm
Bayer has successfully protected "ASPIRIN" worldwide (e.g., Canada, Reg. [read post]
12 Jun 2009, 10:49 am
Bayer AG and Bayer Corp., et al Issue: Are pharmaceutical “reverse payment” agreements - whereby the manufacturer of a brand-name drug (and patent holder) pays a generic manufacturer (and alleged patent infringer) to not launch a generic version of the brand-name drug - per se lawful without regard to the amount of cash paid or the strength of the underlying patent challenge? [read post]
